HERPES VIRUS (HHV 2) - ANVISA Registration 10322250080

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10322250080 and manufactured by manufacturer not specified. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until Jan 02, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASORIN ITALIA S.P.A., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10322250080
2 Related Devices
Registration Details
ANVISA Registration Number: 10322250080
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

artus HSV 1/2 QS RGQ
Risk Class III

Registration Details

10322250080

25351571939201751

01334250000120

Company Information

Dates and Status

Jan 02, 2018

02/01/2028

09/18/2025 19:00:01

artus HSV 1/2 QS RGQ
Risk Class III

Registration Details

10322250080

25351571939201751

01334250000120

Company Information

QIAGEN GMBH
Germany
PT: ALEMANHA

Dates and Status

Jan 02, 2018

02/01/2028

09/18/2025 19:00:01